tiziana
life
sciences
announces
timetable
demerger
accustem
holders
tiziana
adrs
nasdaq
tlsa
new
york
london
globe
newswire
tiziana
life
sciences
plc
nasdaq
tlsa
aim
tils
tiziana
company
biotechnology
company
focused
innovative
therapeutics
oncology
inflammation
infectious
diseases
today
announces
confirming
timetable
accustem
sciences
limited
accustem
demerger
demerger
holders
company
american
depositary
receipts
adrs
demerger
accustem
spinoff
tiziana
stemprinter
novel
genomic
predictor
distant
recurrence
breast
cancer
two
posters
presented
asco
stemprinter
outperformed
oncotype
dx
risk
prediction
breast
cancer
patients
including
lymph
lymph
patients
integration
stem
cell
genomic
tool
stemprinter
clinicopathological
parameters
prediction
distant
recurrence
cancer
patients
demonstrated
stemprinter
riskscore
spare
model
approximately
superior
traditional
clinicopathological
parameters
expressed
cts
providing
prognostic
information
analyzed
accurate
lymph
lymph
patients
timetable
demerger
record
date
distribution
accustem
adrs
holders
tiziana
adrs
follows
final
court
hearing
approve
reduction
capital
october
tiziana
adr
c
register
closure
october
reduction
capital
becomes
effective
october
completion
demerger
october
record
date
holders
adrs
november
dates
holders
tiziana
shares
tiziana
adrs
edt
october
portion
tiziana
adr
register
regarding
issuance
cancellation
adrs
held
jpmorgan
depositary
bank
adr
program
closed
action
completed
action
suspend
nasdaq
trading
tiziana
adss
however
technical
reasons
adr
record
date
established
later
date
due
complexities
us
securities
laws
rules
nasdaq
capital
market
date
holders
tiziana
adrs
traded
nasdaq
dependent
actual
delivery
date
new
accustem
adrs
represent
accustem
shares
mirror
position
tiziana
adrs
different
ex
date
tiziana
shares
purposes
corporate
actions
timetable
london
stock
exchange
plc
difference
economic
impact
holders
adrs
company
plans
file
registration
statement
new
accustem
shares
sec
create
new
registered
accustem
adr
program
accustem
adrs
distributed
holders
tiziana
adrs
record
date
registration
statements
become
effective
likely
date
upon
holders
tiziana
shares
receive
new
accustem
shares
likely
date
upon
new
accustem
shares
admitted
trading
main
market
london
stock
exchange
plc
subject
appropriate
regulatory
review
approvals
company
endeavour
ensure
dates
coincide
events
far
practicable
publish
additional
updates
timelines
due
course
enquiries
united
states
investors
dave
gentry
redchip
companies
office
red
chip
cell
usa
dave
united
kingdom
investors
